
About J3 Bioscience
J3 Bioscience (J3 Bio) is dedicated to advancing women’s health through innovative, safe, and accessible products. Our lead product, LivRing, is built on J3 Bio’s proprietary, patented intravaginal ring (IVR) platform—an advanced reservoir-based system engineered for sustained, localized delivery of therapeutic ingredients. LivRing provides up to 7 days of controlled release of a lubricating vaginal moisturizer for long-lasting relief from vaginal dryness, discomfort, and painful sex. As the longest acting product available in the category, LivRing provides rapid symptom relief while eliminating the need for daily applications or reapplications. In addition to LivRing, J3 Bio’s IVR technology can accommodate a broad spectrum of ingredients and release profiles, creating a versatile platform to address unmet needs in women’s health.
In the News
J3 Bioscience Appoints Dr. Stephanie Singer as Medical Director
June 24, 2025Consumers Find LivRing® Effectively Addresses Needs for Vaginal Dryness Relief
May 21, 2025J3 Bioscience, Inc. Appoints John Fair as New President & CEO
April 3, 2025Management
John Fair President & CEO
R. Tyler McCabe, PhD Co-Founder, COO
Stephanie Singer, DO, FACOG Medical Director
Board of Directors
Tim S. Glassett, JD, MBA Chairman
John Fair
Stath Karras, MBA
Sheryl Kingsberg, PhD
DJ Lee, MD, PhD
Keith Marmer, DPT, MBA
Troy E. Mason
R. Tyler McCabe, PhD
Ron Nielsen
Stephanie Singer, DO, FACOG